SolirisActive Ingredient(s): Eculizumab
FDA Approved: * March 16, 2007
Pharm Company: * ALEXION PHARM
Eculizumab, sold under the brand name Soliris among others, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), and neuromyelitis optica. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted based on small trials.[2&a... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Soliris 300 mg/30ml Intravenous Injection, Solution, ConcentrateNDC: 25682-001
Alexion Pharmaceuticals Inc.
Soliris and pnh
I am looking for information from others who have been taking Soliris. What side effects have you encountered when you f...1 REPLY